MDxHealth SA ADR Asset Resilience Ratio
MDxHealth SA ADR asset resilience ratio. MDxHealth SA ADR (MDXH) has an Asset Resilience Ratio of 0.09% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MDxHealth SA ADR (MDXH) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of MDxHealth SA ADR (2012–2023)
Asset resilience ratio of MDxHealth SA ADR from 2012 to 2023. This chart shows how MDxHealth SA ADR's Asset Resilience Ratio has changed over time. Read MDXH total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down MDxHealth SA ADR's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MDXH total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $110.00K | 0.09% |
| Total Liquid Assets | $110.00K | 0.09% |
Asset Resilience Insights
- Limited Liquidity: MDxHealth SA ADR maintains only 0.09% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
MDxHealth SA ADR Industry Peers by Asset Resilience Ratio
Compare MDxHealth SA ADR's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Diagnósticos da América S.A
SA:DASA3 |
Diagnostics & Research | 10.42% |
|
SMO ClinPlus Co. Ltd.
SHE:301257 |
Diagnostics & Research | 15.78% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
MDxHealth SA ADR Asset Resilience Ratio by Year (2012–2023)
MDxHealth SA ADR asset resilience ratio by year from 2012 to 2023. The table below shows the annual Asset Resilience Ratio data for MDxHealth SA ADR.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.09% | $110.00K | $129.13 Million | +0.00pp |
| 2022-12-31 | 0.08% | $101.00K | $119.14 Million | -0.03pp |
| 2021-12-31 | 0.12% | $89.00K | $75.07 Million | -0.04pp |
| 2020-12-31 | 0.16% | $52.00K | $31.86 Million | +0.04pp |
| 2019-12-31 | 0.13% | $51.00K | $40.63 Million | +0.04pp |
| 2018-12-31 | 0.08% | $54.00K | $65.48 Million | +0.05pp |
| 2017-12-31 | 0.03% | $20.00K | $58.52 Million | -0.10pp |
| 2015-12-31 | 0.14% | $79.00K | $57.74 Million | 0.00pp |
| 2014-12-31 | 0.14% | $43.00K | $30.95 Million | -0.01pp |
| 2013-12-31 | 0.15% | $44.00K | $29.38 Million | +0.06pp |
| 2012-12-31 | 0.08% | $17.00K | $20.00 Million | -- |
About MDxHealth SA ADR
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the… Read more